ICON's Development Solutions division has named Dr. Daniel Tang general manager, Asia Pacific. Tang will lead the development of ICON’s early phase activities across the region, including bioanalytical laboratory services, and the development of strong links with key opinion leaders for early phase clinical testing.
Tang has over 15 years of experience in drug research. Prior to joining ICON, Tang was vice president of operations and bioassay/DMPK of Frontage Laboratories.
“We are very pleased to welcome Dr. Tang to ICON. His expertise, experience and leadership will be critical as we expand our presence and range of services in the Asia Pacific region to support the growing clinical trials market there," said Dr. Mario Rocci, president, ICON Development Solutions.